Your browser doesn't support javascript.
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtre
1.
J Korean Med Sci ; 38(14): e106, 2023 Apr 10.
Article Dans Anglais | MEDLINE | ID: covidwho-2306186

Résumé

BACKGROUND: Recent reports have suggested that pneumonitis is a rare complication following vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, its clinical features and outcomes are not well known. The aim of this study was to identify the clinical characteristics and outcomes of patients with vaccine-associated pneumonitis following vaccination against SARS-CoV-2. METHODS: In this nationwide multicenter survey study, questionnaires were distributed to pulmonary physicians in referral hospitals. They were asked to report cases of development or exacerbation of interstitial lung disease (ILD) associated with the coronavirus disease 2019 vaccine. Vaccine-associated pneumonitis was defined as new pulmonary infiltrates documented on chest computed tomography within 4 weeks of vaccination and exclusion of other possible etiologies. RESULTS: From the survey, 49 cases of vaccine-associated pneumonitis were identified between February 27 and October 30, 2021. After multidisciplinary discussion, 46 cases were analyzed. The median age was 66 years and 28 (61%) were male. The median interval between vaccination and respiratory symptoms was 5 days. There were 20 (43%), 17 (37%), and nine (19%) patients with newly identified pneumonitis, exacerbation of pre-diagnosed ILD, and undetermined pre-existing ILD, respectively. The administered vaccines were BNT162b2 and ChAdOx1 nCov-19/AZD1222 each in 21 patients followed by mRNA-1273 in three, and Ad26.COV2.S in one patient. Except for five patients with mild disease, 41 (89%) patients were treated with corticosteroid. Significant improvement was observed in 26 (57%) patients including four patients who did not receive treatment. However, ILD aggravated in 9 (20%) patients despite treatment. Mortality was observed in eight (17%) patients. CONCLUSION: These results suggest pneumonitis as a potentially significant safety concern for vaccines against SARS-CoV-2. Clinical awareness and patient education are necessary for early recognition and prompt management. Additional research is warranted to identify the epidemiology and characterize the pathophysiology of vaccine-associated pneumonitis.


Sujets)
Vaccins contre la COVID-19 , COVID-19 , Pneumopathie infectieuse , Sujet âgé , Femelle , Humains , Mâle , Ad26COVS1 , Vaccin BNT162 , Vaccin ChAdOx1 nCoV-19 , COVID-19/prévention et contrôle , Vaccins contre la COVID-19/effets indésirables , République de Corée/épidémiologie , SARS-CoV-2 , Vaccination
2.
Sci Rep ; 12(1): 15605, 2022 09 16.
Article Dans Anglais | MEDLINE | ID: covidwho-2069890

Résumé

Frailty is an important risk factor for adverse health-related outcomes. It is classified into several phenotypes according to nutritional state and physical activity. In this context, we investigated whether frailty phenotypes were related to clinical outcome of hospital-acquired pneumonia (HAP). During the study period, a total of 526 patients were screened for HAP and 480 of whom were analyzed. The patients were divided into four groups according to physical inactivity and malnutrition: nutritional frailty (Geriatric Nutritional Risk Index [GNRI] < 82 and Clinical Frailty Scale [CFS] ≥ 4), malnutrition (GNRI < 82 and CFS < 4), physical frailty (GNRI ≥ 82 and CFS ≥ 4), and normal (GNRI ≥ 82 and CFS < 4). Among the phenotypes, physical frailty without malnutrition was the most common (39.4%), followed by nutritional frailty (30.2%), normal (20.6%), and malnutrition (9.8%). There was a significant difference in hospital survival and home discharge among the four phenotypes (p = 0.009), and the nutritional frailty group had the poorest in-hospital survival and home discharge (64.8% and 34.6%, respectively). In conclusion, there were differences in clinical outcomes according to the four phenotypes of HAP. Assessment of frailty phenotypes during hospitalization may improve outcomes through adequate nutrition and rehabilitation treatment of patients with HAP.


Sujets)
Syndrome de fatigue chronique , Fragilité , Pneumonie associée aux soins , Malnutrition , Sujet âgé , Exercice physique , Syndrome de fatigue chronique/complications , Fragilité/complications , Évaluation gériatrique , Hôpitaux , Humains , Malnutrition/étiologie
3.
Applied Sciences ; 11(24):12009, 2021.
Article Dans Anglais | MDPI | ID: covidwho-1581065

Résumé

This study introduces Action Research to present a service program through an interdisciplinary service design approach for promoting the residential stability of elderly people. We extracted design elements (1) “things to do”and (2) “community”and “strategies”, and then made a design framework. According to the framework, we developed a service design program, named “Small Daily Life: “Small Daily Life Tasks”, which provided opportunities to share the elderly people’s daily life via online videos “Small Meeting”, which helped develop a network of relationships outside the home by informing neighbors regarding elderly people’s know-how, and “Small Sharing”, which delivers the results of previous activities to those who need help in the community. Finally, we describe our reflective case study on the presented service program and examine the relationship between social infrastructure and design and their respective roles. This study will expand service design methodologies as presented research procedures, generalized frameworks, and conceptual models that can be referenced in multidisciplinary collaborations.

SÉLECTION CITATIONS
Détails de la recherche